HIV-associated autoimmune hemolytic anemia: an update

Area of Science:

• Hematology
• Immunology
• Infectious Diseases

Background:

• Patients with human immunodeficiency virus (HIV) often develop hematologic disorders beyond immunosuppression and opportunistic infections.
• Common complications include cytopenias (anemia, thrombocytopenia, leukopenia) and bone marrow dysplasia.
• Hemostatic abnormalities and thromboembolism risk are also recognized in HIV patients.

Purpose of the Study:

• To review the etiology, pathophysiology, clinical features, diagnosis, treatment, and complications of autoimmune hemolytic anemia (AIHA) in the context of HIV infection.
• To highlight the increased incidence of positive Coombs' tests in acquired immune deficiency syndrome (AIDS) patients, indicating autoimmune hemolytic anemia.
• To discuss overt hemolysis as a rare but significant complication.

Main Methods:

• This is a review article.
• It synthesizes existing literature on AIHA associated with HIV.
• Information is gathered on etiology, pathophysiology, clinical presentation, diagnostic methods, therapeutic strategies, and potential complications.

Main Results:

• Anemia in HIV patients is often multifactorial.
• There is an increased incidence of autoimmune hemolytic anemia (AIHA) in HIV/AIDS patients, evidenced by a higher rate of positive Coombs' tests.
• Overt hemolysis is an uncommon but serious manifestation.

Conclusions:

• Autoimmune hemolytic anemia (AIHA) is a recognized hematologic complication in HIV-infected individuals.
• Understanding the multifaceted nature of AIHA in HIV is crucial for effective patient management.
• Further research may elucidate specific mechanisms and optimize treatment protocols for this patient population.